Abstract
The more severe phenotype of mice lacking CD19 as compared to CD21 suggests that a complement-independent ligand for the CD19/CD21 complex exists. We sought ligands for CD19 by examining binding reactions with fusion proteins comprised of the extracellular region of CD19 and the Fc region of IgG1. A fusion protein containing the third extracellular domain (D3-Fc) bound to WEHI-231 cells, and this was competed by soluble IgM. This function of IgM was confirmed by the binding of D3-Fc to beads coated with IgM. A second ligand for D3-Fc was found on stromal cells, and was shown to be heparin/heparan sulfate. These two ligands would be considered to reside on follicular dendritic cells, and may account for the observed ability of D3-Fc to bind to sites in germinal centers containing these cells.
Author supplied keywords
Cite
CITATION STYLE
De Fougerolles, A. R., Batista, F., Johnsson, E., & Fearon, D. T. (2001). IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19. European Journal of Immunology, 31(7), 2189–2199. https://doi.org/10.1002/1521-4141(200107)31:7<2189::AID-IMMU2189>3.0.CO;2-V
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.